You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 296 No. 8, August 23/30, 2006 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related letters
 •Similar articles in JAMA
 Topic Collections
 •Humanities
 •Medicine and the Media
 •Journalology/ Peer Review/ Authorship
 •Conflict of Interest
 •Medical Ethics
 •Alert me on articles by topic

The Influence of Money on Medical Science

Catherine D. DeAngelis, MD, MPH

JAMA. 2006;296:996-998. Published online August 7, 2006 (doi:10.1001/jama.296.8.jed60051).

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

While on vacation recently, I had the opportunity to contemplate the sometimes unethical influence of money on medical science, a very serious issue, which has become more evident over the past year or so. It seemed ironic that this wonderful time of contemplation was aided by the soothing, normal flow of the Delaware River in Pennsylvania, which just a week before had deluged roaring destructive flood waters well beyond its normal banks. Such is the nature of Nature, which very much mimics the pattern of my thoughts over the past few weeks as I experienced what happened as a result of trying to address a serious problem.

There can be no doubt that editors of peer-reviewed medical journals must always place the interest of patients above all else. Every published article eventually can and should affect patient care. Therefore, all articles that we publish must . . . [Full Text of this Article]

Author Affiliation: Dr DeAngelis is Editor in Chief, JAMA (cathy.deangelis@jama-archives.org).


RELATED LETTERS

Financial Disclosure Policies of Scientific Publications
Laura M. Brockway and Leo T. Furcht
JAMA. 2006;296(24):2925-2926.
EXTRACT | FULL TEXT  

Financial Disclosure Policies of Scientific Publications—Reply
Catherine D. DeAngelis
JAMA. 2006;296(24):2926.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Issues in the Registration of Clinical Trials
Zarin et al.
JAMA 2007;297:2112-2120.
ABSTRACT | FULL TEXT  

The Role of Litigation in Defining Drug Risks
Kesselheim and Avorn
JAMA 2007;297:308-311.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2006 American Medical Association. All Rights Reserved.